News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celgene (CELG)'s Thalidomide May Help Patients With Deadly Lung Disease


9/18/2012 8:07:15 AM

In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that taking thalidomide significantly reduced the cough and improved quality of life. Results of their study are published in the Annals of Internal Medicine on Sept. 18, 2012, in an article titled "Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis."

Read at News Release
Read at Bloomberg
Read at ABC News
Read at News Release
Read at News Release

comments powered by Disqus
Celgene
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES